Anesthesia adjunct injection recalled due to possible presence of glass

Administration may result in local irritation or swelling in response to the foreign material

Anesthesia adjunct injection recalled due to possible presence of glass
Vecuronium Bromide

(KPLC) - Sun Pharmaceutical Industries, Inc. is voluntarily recalling certain lots of Vecuronium Bromide for Injection to the hospital level, according to the FDA.

The affected injections have been found to contain particulate matter identified as glass, said the FDA. If the glass particulate is found present in an intravenous drug, it may result in local irritation or swelling in response to the foreign material. More serious potential outcomes would include blockage and clotting in blood vessels, which may be life-threatening.

The lots affected include:

  • three lots of Vecuronium Bromide for Injection, 10 mg
  • one lot of Vecuronium Bromide for Injection, 20 mg

Vecuronium Bromide for Injection is used as an adjunct to general anesthesia, to facilitate endotracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It should be administered by or under the supervision of experienced clinicians and must be reconstituted prior to use.

Sun Pharmaceutical Industries have not received any reports of adverse events related to this recall. The product is distributed nationwide to wholesale customers and medical facilities.

See more details HERE.

Vecuronium Bromide
Vecuronium Bromide (Source: FDA)

Copyright 2019 KPLC. All rights reserved.